Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2023-02-28 00:00:00 ET · period of report 2023-02-26 · accession 0001055726-23-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-28 | 2023-02-26 | INO | KIES PETER | CFO | M - OptEx | — | +70.5K | 236.9K | +42% | — |
| DM | 2023-02-28 | 2023-02-26 | INO | KIES PETER | CFO | F - Tax | $1.28 | -41.1K | 208.7K | -16% | -$52.6K |
| D | 2023-02-28 | 2023-02-27 | INO | KIES PETER | CFO | A - Grant | $0.00 | +225.0K | 225.0K | New | $0 |
| DM | 2023-02-28 | 2023-02-26 | INO | KIES PETER | CFO | M - OptEx | $0.00 | -70.5K | 95.9K | -42% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-26 | M | A | 22,544 | — | 201,828 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 2 | Common | Common Stock | 2023-02-26 | M | A | 47,967 | — | 236,867 | D | — | — | (F3) Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 143,900 restricted stock units, vesting as follows: 47,967 shares vested on February 26, 2023; 47,967 shares will vest on February 26, 2024; and 47,966 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 3 | Common | Common Stock | 2023-02-26 | F | D | 12,928 | $1.28 | 188,900 | D | — | — | |
| 4 | Common | Common Stock | 2023-02-26 | F | D | 28,195 | $1.28 | 208,672 | D | — | — | |
| 5 | Derivative | Common Stock Option | 2023-02-27 | A | A | 225,000 | $0.00 | 225,000 | D | $1.24 · 2023-02-27 to 2033-02-27 | 225,000 Common Stock | (F5) The vesting schedule for the 225,000 options is as follows: 56,250 shares vested on February 27, 2023; 56,250 shares will vest on February 26, 2024; 56,250 shares will vest on February 26, 2025; and 56,250 shares will vest on February 26, 2026. |
| 6 | Derivative | Restricted Stock Unit | 2023-02-26 | M | D | 22,544 | $0.00 | 22,544 | D | — · — to — | 22,544 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 7 | Derivative | Restricted Stock Unit | 2023-02-26 | M | D | 47,967 | $0.00 | 95,933 | D | — · — to — | 47,967 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 143,900 restricted stock units, vesting as follows: 47,967 shares vested on February 26, 2023; 47,967 shares will vest on February 26, 2024; and 47,966 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |